If you liked this article you might like

Biotech Needs a Shot in the Arm
Market Recon: Worryingly, the Indices Seem to Be Almost Resting at Lofty Levels
Biotech Stock Mailbag: Why Clovis Oncology Is Trading Lower on Rubraca Study Update
Tesaro Resorts to PR Razzle Dazzle to Make Ovarian Cancer Drug Appear Cheaply Priced